Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19), 2021, Boscolo-Rizzo et al

Discussion in 'Long Covid research' started by Andy, Jun 11, 2021.

  1. Andy

    Andy Committee Member

    Messages:
    22,392
    Location:
    Hampshire, UK
    INTRODUCTION

    Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection can cause a wide array of symptoms ranging from mild to severe or fatal forms of coronavirus disease 2019 (COVID-19).1 Furthermore, it has been observed that in a proportion of patients a variable range of symptoms may persist for a long time.2

    An increasing number of studies have been focused on long COVID, but they have mainly been concentrated on previously hospitalized severe COVID-19 patients reporting symptoms up to 6-months after illness.3, 4 The main aim of this study was to evaluate the prevalence of COVID-related symptoms 12-months after the onset of mild-to-moderate disease.

    Open access, https://onlinelibrary.wiley.com/doi/10.1002/alr.22832
     

Share This Page